• Amy J Keenum, Jennifer E Devoe, Deena J Chisolm, and Lorraine S Wallace.
• Department of Family Medicine, University of Tennessee Graduate School of Medicine, Knoxville, 37920, USA. akeenum@mc.utmck.edu
• Res Social Adm Pharm. 2012 Nov 1;8(6):574-8.

BackgroundBecause generic medications are less expensive than brand-name medications, government and private insurers have encouraged and/or mandated the use of generics.ObjectiveThis study aimed at evaluating perceptions about generic medications among English-speaking women of childbearing age currently enrolled in U.S. TennCare (Medicaid).MethodsWe recruited a convenience sample of patients from the waiting room of a primary care/gynecology health clinic, with 80% recruitment rate among those approached. We orally administered a 25-item questionnaire to gather sociodemographic information and to assess beliefs regarding the efficacy, safety, cost, and preferences for personal use of generic medications.ResultsThe average age of the women (n=172) was 28.8 ± 6.4 years, and most were white (82.0%) and currently married (58.1%). Nearly one-fifth (19.2%) had not completed high school. Most women believed that generic medications were less expensive (97.6%) and better value (60.5%) than brand-name medications, but only 45.3% preferred to take generics themselves. About a quarter (23.3%) believed that brand-name medications were more effective than generics, whereas 13.4% believed that generics caused more side effects. Few women reported that their doctor (29.7%) and/or pharmacist (35.5%) had ever talked to them about taking generics.ConclusionAwareness of the benefits of generics did not equal preferences for personal use of generics among this sample of women enrolled in U.S. TennCare. Furthermore, women reported that providers-both physicians and pharmacists-infrequently discussed generic substitution with them.Copyright © 2012 Elsevier Inc. All rights reserved.

30 keywords...

hide…